Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
GERN
#2376
Geron Corp
1.7
7
USD
+2.31%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+2.31%
Aylık Değişim
+11.32%
6 aylık değişim
+39.37%
Yıllık Değişim
+35.11%
Önceki Kapanış
1.7
3
Open
1.7
7
Bid
Ask
Low
1.7
7
High
1.7
7
Hacim
71
Piyasalar
ABD Borsası
Sağlık Hizmetleri
GERN
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
318.53 M
323.73 M
508.72 M
546.06 M
636.9 M
640.54 M
—
Valuation ratios
Enterprise value
526.25 M
414.18 M
1.2 B
1.14 B
2.3 B
888.95 M
3.8 B
Price to earnings ratio
—
—
-6.49
-6.69
-13.11
-10.15
-39.99
Price to sales ratio
—
—
1 533.36
5 152.66
-1 339.75
—
—
Price to cash flow ratio
—
—
-7.17
-7.28
-10.46
-7.93
-25.05
Price to book ratio
—
—
11.42
4.93
8.16
3.9
6.51
Enterprise value to EBITDA ratio
-6.55
-3.22
-8.42
-5.38
-8.2
-2.97
—
Profitability ratios
Return on assets %
-0.28
-0.51
-0.74
-0.47
-0.29
-0.15
-0.15
Return on equity %
-0.36
-0.92
-1.77
-0.74
-0.62
-0.37
-0.34
Return on invested capital %
-370.38
-500.89
-861.79
-727.02
-533.33
-95.12
—
Gross margin %
100
100
100
100
100
—
—
Operating margin %
-30.4 K
-8 183.7
-23.25 K
-81.83 K
10.18 K
—
—
EBITDA margin %
-29.94 K
-8 017.37
-23.19 K
-86.08 K
15.54 K
—
—
Net margin %
-29.89 K
-8 335.39
-23.81 K
-77.69 K
10.23 K
—
—
Liquidity ratios
Quick ratio
—
—
—
—
5.12
3.62
22.25
Current ratio
6.46
4.11
2.35
3.16
5.56
4.66
26.35
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.01
0
0
-0
0
—
Solvency ratios
Debt to assets ratio
0.11
0.24
0.18
0.1
0.2
0.21
0.86
Debt to equity ratio
0.14
0.43
0.42
0.15
0.43
0.54
1.94
Long term debt to total assets ratio
0.09
0.22
0.16
0.09
0.2
0.21
0.85
Long term debt to total equity ratio
0.11
0.39
0.38
0.14
0.42
0.53
1.91
Per share metrics
Operating cash flow per share
—
—
-0.33
-0.29
-0.34
-0.17
-0.17
EBIT per share
—
—
-0.36
-0.34
-0.39
-0.38
—
EBITDA per share
—
—
-0.36
-0.36
-0.41
-0.39
—
Total debt per share
—
—
0.09
0.07
0.19
0.18
0.73
Cash per share
—
—
0.45
0.58
0.63
0.12
0.48
Net current asset value per share
—
—
0.47
0.6
0.76
0.78
3.07
Tangible book value per share
—
—
0.21
0.43
0.43
0.34
1.5
Working capital per share
—
—
0.27
0.41
0.62
0.61
2.58
Book value per share
—
—
0.21
0.43
0.43
0.34
1.5
Geron Corporation
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
Haberler
Geron, Timothy Williams’ı hukuk müdürü olarak atadı
Geron yönetim kuruluna iki yeni üye atadı
Geron Barclays Sağlık Konferansı’nda: Stratejik Büyüme ve Planlar
Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans
Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
Geron TD Cowen’da: Stratejik Büyüme ve Pazar Genişlemesi
Geron at TD Cowen: Strategic Growth and Market Expansion
Geron: Why I'm Doubling Down On My 'Sell' Rating After Q4 Earnings (NASDAQ:GERN)
Geron Corporation (GERN) Q4 2025 Earnings Call Transcript
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
Geron kazancı $0,02 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük